Medtronic Quietly Raised Its Dividend Again. Is It a Buy for Income Investors?

Medtronic just extended a nearly half-century dividend streak, but its raise barely outpaces inflation while rivals like Abbott and J&J grow payouts far faster. Whether explosive growth in cardiac ablation can close that gap is the real question for income investors eyeing this stock.